Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1168 | 1168 | 1323 | 1447 | 1830 | 3365 |
Fund Return | 16.84% | 16.84% | 32.33% | 13.09% | 12.85% | 12.9% |
Place in category | 33 | 33 | 43 | 76 | 58 | 27 |
% in Category | 9 | 9 | 15 | 37 | 37 | 25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AMP Capital Future Directions Balan | 8.24B | -7.90 | 4.24 | 8.00 | ||
Ipac Select Index Balanced | 5.06B | 5.81 | 6.46 | 7.48 | ||
North Index Balanced | 5.06B | 5.81 | 6.46 | 7.48 | ||
Ipac Select Index Growth | 2.99B | 7.13 | 8.13 | 8.67 | ||
North Index Growth | 2.99B | 7.13 | 8.13 | 8.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard International Shares Inde | 36.96B | 13.98 | 14.48 | 13.52 | ||
Arrowstreet Global Equity Fund | 9.16B | 16.34 | 15.32 | 15.05 | ||
Dimensional Global Core Equity Trus | 7.23B | 13.39 | 13.57 | 11.80 | ||
AMP Capital Specialist Internation | 2.84B | 16.87 | 11.42 | 12.48 | ||
BlackRock Indexed International Equ | 2.13B | 14.01 | 14.52 | 13.60 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Orbis Global Eq LE Fd (Aus Registered) | AU60ETL27611 | 18.29 | - | - | |
Microsoft | US5949181045 | 3.37 | 406.32 | +1.82% | |
Apple | US0378331005 | 1.84 | 169.30 | -0.35% | |
UnitedHealth | US91324P1021 | 1.70 | 495.42 | +0.32% | |
Alphabet C | US02079K1079 | 1.34 | 173.69 | +9.97% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review